DecorteJoseph Profile Banner
Joseph DeCorte Profile
Joseph DeCorte

@DecorteJoseph

Followers
102
Following
5K
Statuses
108

Vandy MSTP | Interests: math, chemistry, immunology. Forbes N under N as N approaches infinity. Maybe Maybe not.

Nashville, TN, USA
Joined December 2020
Don't wanna be here? Send us removal request.
@DecorteJoseph
Joseph DeCorte
4 days
RT @jaygirimd: 🧵 Many “hot takes” about the reduction of @NIH indirect grant costs to 15%. Let’s lay out the facts about the university g…
0
304
0
@DecorteJoseph
Joseph DeCorte
9 days
RT @dbaek__: 1/9 🚨 New Paper Alert: Cross-Entropy Loss is NOT What You Need! 🚨 We introduce harmonic loss as alternative to the standard CE…
0
549
0
@DecorteJoseph
Joseph DeCorte
18 days
RT @AJamesMcCarthy: I captured the entire "Planetary Parade" using my 11" telescope, and combined everything into one composite photo that…
0
13K
0
@DecorteJoseph
Joseph DeCorte
22 days
RT @MSchleifstein: Louisiana winter wonderland via NASA Worldview (NASA GOES-East at 9:30 a.m. 1/22/25)
Tweet media one
0
824
0
@DecorteJoseph
Joseph DeCorte
22 days
RT @MathMatize: No way
Tweet media one
0
291
0
@DecorteJoseph
Joseph DeCorte
1 month
Final version of BCL-XpKa, a small-molecule pKa predictor within the Meiler lab’s open-source cheminformatics platform, is now published in the Journal of Chemical Information and Modeling. @MeilerLab
@ML_Chem
Machine Learning in Chemistry
1 month
Interpretable Deep-Learning pKa Prediction for Small Molecule Drugs via Atomic Sensitivity Analysis #machinelearning #compchem
1
0
4
@DecorteJoseph
Joseph DeCorte
2 months
RT @DrChoueiri: IT IS THIS TIME OF THE YEAR AGAIN! TOP 10 GU Bladder/Kidney Cancer TRIALS FOR 2024 1/ Enfortumab Vedotin (EV) + Pembroliz…
0
242
0
@DecorteJoseph
Joseph DeCorte
2 months
Long Placebovant Therapeutics
@GooseData
Goose Data (wa/wa)
2 months
Long placebo!
Tweet media one
0
0
1
@DecorteJoseph
Joseph DeCorte
2 months
Sorta what real analysis feels like
@chinesegon
gon
2 months
no one: guys getting paid 3x your salary:
Tweet media one
0
0
1
@DecorteJoseph
Joseph DeCorte
3 months
RT @NEJM: In the COMBI-AD trial, researchers evaluated whether adjuvant therapy with the BRAF-targeted agent dabrafenib plus the MEK inhibi…
0
4
0
@DecorteJoseph
Joseph DeCorte
3 months
@QuantPsychiatry Grest thread, Zack!
0
0
1
@DecorteJoseph
Joseph DeCorte
3 months
Woah
@BaranLabReads
Baran Lab
3 months
Finally, RADICAL CROSS COUPLING without the exogenous REDOX. We disclose in @ChemRxiv ( a broadly general platform for achieving transformations that normally required excess metallic or chemical reducing agents or photochemical setups (and their requisite catalysts) or potentiostats for electrochemistry. Now, such transformations can be accomplished with the same ease that one conducts a Suzuki coupling. You can scale up (its homogeneous) or scale down (use cheap parallel screening plates). Moisture is tolerated and base metal catalysis is used. As the best engineers like to say, "The best part is no part". Now, chemists have the option to remove the redox part from radical couplings. Quick Summary: Sulfonyl hydrazides are disclosed as versatile radical precursors as exemplified with seven new C–C bond forming, redox-neutral cross-couplings with: (1) activated olefins, (2) alkyl halides, (3) redox active esters, (4) aryl halides, (5) alkenyl halides, (6) alkynyl halides, and (7) a trifluoromethylating reagent to forge C(sp3)-C(sp3), C(sp3)-C(sp2), and C(sp3)-C(sp) bonds. Sulfonyl hydrazides are stable and usually crystalline substances that can be accessed in a variety of ways including transiently from hydrazones to achieve a net reductive arylation of carbonyl compounds. Exogenous redox (chemical, photo/electrochemical) additives are not necessary as these functional groups serve the dual role of radical precursor and electron donor. The operational simplicity (homogeneous, water tolerant, dump-and-stir) and practicality of the method are demonstrated as well as applications to streamlining synthesis and mild late-stage functionalization.
Tweet media one
0
0
1
@DecorteJoseph
Joseph DeCorte
4 months
RT @burrhhh: Your diagrams need to be scaring your collaborators. If your diagram doesn’t look like a sentient being you’re doing it wrong.
0
8
0
@DecorteJoseph
Joseph DeCorte
4 months
RT @NASA: Behold: a full moon worthy of the Halloween season. The Hunter’s Moon! According to the Farmer’s Almanac, this month’s full moon…
0
3K
0
@DecorteJoseph
Joseph DeCorte
4 months
John’s one of the most genuine and humble scientists I’ve met. At a lunch a few months back, he attributed AlphaFold’s success to an accumulation of incremental progress made by a driven team, rather than some classic scientific “Eureka” moment. …Wait I thought ML was physics?
@NobelPrize
The Nobel Prize
4 months
BREAKING NEWS The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Chemistry with one half to David Baker “for computational protein design” and the other half jointly to Demis Hassabis and John M. Jumper “for protein structure prediction.”
Tweet media one
1
0
1
@DecorteJoseph
Joseph DeCorte
4 months
RT @miniapeur: No incident at the topological factory.
Tweet media one
0
388
0
@DecorteJoseph
Joseph DeCorte
4 months
RT @the_codedog: cd ../ ls cd ../ ls cd ../ ls
Tweet media one
0
3K
0
@DecorteJoseph
Joseph DeCorte
4 months
RT @docmilanfar: A surprising & little-known results in classical statistics: mean (μ) and median (m) are within one std deviation: |μ−m|…
0
210
0
@DecorteJoseph
Joseph DeCorte
5 months
RT @NatRevDrugDisc: FDA approves first schizophrenia drug with a new mechanism of action since the 1950s Karuna/…
0
262
0